[1] Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008;359(5):492-507.
[2] Wu JS, Zhang J, Zhuang DX, et al. Current status of cerebral glioma surgery in China. Chin Med J (Engl). 2011;124(17): 2569-2577.
[3] 赖华生,陈志浩,陈祎招.神经胶质瘤与新型抑癌基因的研究进展[J].广东医学,2015,36(7):1122-1124.
[4] 叶振南,徐善水.miRNA 在胶质瘤组织和细胞中的表达及作用[J].山东医药,2013,53(33):100-102.
[5] Tabatabai G, Weller M. Glioblastoma stem cells. Cell Tissue Res. 2011;343(3):459-465.
[6] Bier A, Giladi N, Kronfeld N, et al. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1. Oncotarget. 2013; 4(5):665-676.
[7] Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature. 2004;432(7015): 396-401.
[8] Fan X, Salford LG, Widegren B. Glioma stem cells: evidence and limitation. Semin Cancer Biol. 2007;17(3):214-218.
[9] Stiles CD, Rowitch DH. Glioma stem cells: a midterm exam. Neuron. 2008;58(6):832-846.
[10] Fine HA. Glioma stem cells: not all created equal. Cancer Cell. 2009;15(4):247-249.
[11] Wang J, Wakeman TP, Lathia JD, et al. Notch promotes radioresistance of glioma stem cells. Stem Cells. 2010;28(1): 17-28.
[12] Pasquinelli AE. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet. 2012;13(4):271-282.
[13] Ameres SL, Zamore PD. Diversifying microRNA sequence and function. Nat Rev Mol Cell Biol. 2013;14(8):475-488.
[14] Hausser J, Zavolan M. Identification and consequences of miRNA-target interactions--beyond repression of gene expression. Nat Rev Genet. 2014;15(9):599-612.
[15] Friedman RC, Farh KK, Burge CB, et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19(1):92-105.
[16] 王影,孙静,李艳艳,等.miR-29a对胶质瘤细胞CDC42表达及迁移和侵袭的影响[J].中国肿瘤临床,2013,40(11):629-633.
[17] 石翠娟,王影,于士柱,等.胶质瘤 miR-29c 表达异常减少及其对肿瘤细胞增殖的影响[J].中国肿瘤临床,2015,42(1):47-52.
[18] 王宏勤,王新星,苗旺,等.MiR-195对胶质瘤细胞 U251 增殖和凋亡的影响[J].中华神经外科杂志,2013,29(5):473-477.
[19] 刘锋,王占祥,黄才权,等.miR-200a 通过靶向NCAM1基因影响胶质瘤细胞的迁移及侵袭[J].肿瘤,2013,33(5):398-403.
[20] Shi L, Cheng Z, Zhang J, et al. hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res. 2008;1236:185-193.
[21] Huse JT, Brennan C, Hambardzumyan D, et al. The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev. 2009;23(11):1327-1337.
[22] Song L, Huang Q, Chen K, et al. miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-β. Biochem Biophys Res Commun. 2010;402(1):135-140.
[23] Silber J, Lim DA, Petritsch C, et al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 2008;6:14.
[24] Guessous F, Zhang Y, Kofman A, et al. microRNA-34a is tumor suppressive in brain tumors and glioma stem cells. Cell Cycle. 2010;9(6):1031-1036.
[25] Shi L, Zhang J, Pan T, et al. MiR-125b is critical for the suppression of human U251 glioma stem cell proliferation. Brain Res. 2010;1312:120-126.
[26] Gal H, Pandi G, Kanner AA, et al. MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells. Biochem Biophys Res Commun. 2008;376(1):86-90.
[27] Wang J, Tian X, Han R, et al. Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer. Oncogene. 2014; 33(9):1181-1189.
[28] Rask L, Balslev E, Søkilde R, et al. Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status. Cell Oncol (Dordr). 2014;37(3):215-227.
[29] 刘振林,刘晓智,陈镭,等.CD133+胶质母细胞瘤细胞的分离与恶性行为特征[J].中国神经肿瘤杂志,2012,10(2):84-89.
[30] 许晶廷, 程洋,姚一龙,等 MiR-144 对人脑胶质瘤干细胞的生物学行为的影响[J].解剖科学进展,2015,2:3.
[31] 陈垒. MicroRNA-107 在胶质瘤和胶质瘤干细胞中的生物学功能研究[D].广州: 南方医科大学,2013.
[32] Kruyt FA, Schuringa JJ. Apoptosis and cancer stem cells: Implications for apoptosis targeted therapy. Biochem Pharmacol. 2010;80(4):423-430.
[33] Dean M. ABC transporters, drug resistance, and cancer stem cells. J Mammary Gland Biol Neoplasia. 2009;14(1):3-9.
[34] Malanchi I, Santamaria-Martínez A, Susanto E, et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature. 2011;481(7379):85-89.
[35] Sampieri K, Fodde R. Cancer stem cells and metastasis. Semin Cancer Biol. 2012;22(3):187-193.
[36] 徐国政,袁先厚.脑胶质瘤靶向治疗新进展[J].中国临床神经外科杂志,2011,16(9):568-572.
[37] 尤永平,刘宁,傅震.中国胶质瘤规范化治疗现状[J].中国肿瘤外科杂志,2012,4(3):129-131.
[38] Sun JH,Guo M,Pang HY,et al.Treatment of malignant glioma using hyperthermia.Neural Regen Res. 2013;8 (29): 2775-2782
[39] 刘华亭,杨天明.神经胶质瘤的治疗策略[J].现代生物医学进展, 2011,11(5):958-960.
[40] 高岩.人脑胶质瘤中PTEN及PI3K/AKT/GSK-3相关蛋白表达的研究[D].南京:南京医科大学,2012.
[41] Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003; 63(18):5821-5828. |